Exosomal Transfer of lncRNA H19 Promotes Erlotinib Resistance in Non-Small Cell Lung Cancer via miR-615-3p/ATG7 Axis

BACKGROUND: Drug resistance restrains the effect of drug therapy in non-small cell lung cancer (NSCLC). However, the mechanism of the acquisition of drug resistance remains largely unknown. This study aims to investigate the effect of exosomal lncRNA H19 on erlotinib resistance in NSCLC and the unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Rongtao, Zhou, Haiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294568/
https://www.ncbi.nlm.nih.gov/pubmed/32606925
http://dx.doi.org/10.2147/CMAR.S241095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294568/
https://www.ncbi.nlm.nih.gov/pubmed/32606925
http://dx.doi.org/10.2147/CMAR.S241095

Ejemplares similares